Treatment of West Nile Virus With MGAWN1
Is a
Allocation Type
Randomized
0
Health Conditions in Trial
Intervention Model
Parallel Assignment
0
Intervention Name
Placebo - normal saline
0
MGAWN1
0
Interventional Trial Phase
Phase 2
0
Interventional Trial Purpose
Treatment
0
Intervention Type
Biological
0
Last Updated
February 10, 2022
0
Masked Party
Care Provider
0
Participant
0
Outcomes Assessor
0
Investigator
0
Masking Type
Quadruple
0
Primary Completion Date
2011
0
Trial Recruitment Size
13
0
Trial Sponsor
Clinical Trial Start Date
2009
0
Study Completion Date
2011
0
Clinical Trial Study Type
Interventional
0
NCT Number
Official Name
Phase 2, Stratified, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety and Efficacy of MGAWN1 in Subjects With Laboratory-documented West Nile Fever or Suspected Central Nervous System Infection Due to West Nile Virus
0
Official Website
Find more entities like Treatment of West Nile Virus With MGAWN1
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.